Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP992852priorityCriticalpatent/ECSP992852A/en
Publication of ECSP992852ApublicationCriticalpatent/ECSP992852A/en
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Formulaciones farmacéuticas que comprenden una eptilona en la forma de un concentrado para infusión, o una composición liofilizada, y métodos para la administración de una epotilona, en una forma adecuada para su administración parenteral.Pharmaceutical formulations comprising an epilone in the form of a concentrate for infusion, or a lyophilized composition, and methods for the administration of an epothilone, in a form suitable for parenteral administration.
USE OF CLORPROMAZINE AND PENTAMIDINE FOR THE MANUFACTURE OF MEDICINES, PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL PACKAGE THAT INCLUDE CHLORPROMAZINE AND PENTAMIDINE.
11-beta-phenylestradiene derivatives with fluoroalkyl groups in the aromatic side chain, production thereof and pharmaceutical compositions containing these compounds
DERIVATIVES OF 17-HYDROXYIMINOALKYL AND 17-HYDROXYIMINOMETILALQUENIL CICLOPENTANPERHIDROFENANTRENO ACTIVE IN THE CARDIOVASCULAR SYSTEM A PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.